MSF Capital’s Elevance Health ELV Stock Holding History

MSF Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,445	Closed	-$2.15M	–	5
2015 Q4	$2.15M	Sell	15,445 -27,115	-64%	-$3.74M	7.1%	4
2015 Q3	$5.96M	Buy	+42,560	New	+$6.4M	1.53%	19
2015 Q1	–	Sell	-56,246	Closed	-$7.07M	–	45
2014 Q4	$7.07M	Sell	56,246 -4,147	-7%	-$512K	1.68%	18
2014 Q3	$7.22M	Sell	60,393 -16,627	-22%	-$1.91M	1.7%	22
2014 Q2	$8.29M	Sell	77,020 -17,557	-19%	-$1.81M	1.87%	19
2014 Q1	$9.41M	Sell	94,577 -2,041	-2%	-$185K	2.12%	14
2013 Q4	$8.93M	Sell	96,618 -27,084	-22%	-$2.41M	2.03%	13
2013 Q3	$10.3M	Buy	+123,702	New	+$10.6M	2.51%	11
2013 Q2	–	Hold	0	–	–	–	6

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MSF Capital's ELV Position: Q1 2016 in Review

MSF Capital sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 15,445 shares — an estimated $2.15M sold.

MSF Capital first reported a position in ELV in Q3 2013 and held it in 8 quarters. The position peaked at $10.3M in Q3 2013. 772 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

MSF Capital reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
MSF Capital sold 15,445 Elevance Health shares in Q1 2016, an estimated $2.15M.
MSF Capital first reported a position in Elevance Health in Q3 2013 and held it in 8 quarters.
MSF Capital's Elevance Health position peaked at $10.3M in Q3 2013.
772 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on MSF Capital's 13F filing for Q1 2016.